The Tät II app study begins 3 April!
We have developed a new app – the app Tät®II – for the treatment of urge- and mixed-incontinence. This app will be evaluated in a new study to see if it is effective. Press release (in Swedish)
We have developed a new app – the app Tät®II – for the treatment of urge- and mixed-incontinence. This app will be evaluated in a new study to see if it is effective. Press release (in Swedish)
The app Tät® contains information, pelvic floor exercise programmes in 6 basic steps and 6 advanced steps, a facility for creating reminders, and a statistical function. The app was developed and evaluated in our research.
Swedish and English versions are now available free of charge for iOS on the App Store and for Android on Google Play, read more (in English).
We have previously described the successful results from the randomized controlled study of our app Tät for the treatment of stress incontinence. As well as being published in a scientific journal Neurourology and Urodynamics the study has now featured in the American news magazine Time, see link.
The app Tät® contains information, pelvic floor exercise programmes in 6 basic steps and 6 advanced steps, a facility for creating reminders, and a statistical function. The app has been developed from our research.
Besides being available in Swedish for iOS on the App store and for Android on Google Play, there is now an English version for Android available free of charge on Google Play, read more (in English).
The treatment of stress incontinence via the internet or via the booklet has been shown to also produce good long-term results. In the article ”Non-face-to-face treatment of stress urinary incontinence: predictors of success after 1 year“ we have examined what the predictors are for successful results after one year. The results at the 1-year follow-up were found to be more successful in those women who achieved successful results from the pelvic floor exercises after 4 months, those who exercised regularly in the final month before the 1-year follow-up, and in older subjects.